BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23751152)

  • 1. Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery.
    Ibrahim ZM; Sayed Ahmed WA
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):300-8. PubMed ID: 23751152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial.
    Abdellah MS; Abbas AM; Hegazy AM; El-Nashar IM
    Contraception; 2017 Jun; 95(6):538-543. PubMed ID: 28088498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial.
    Sääv I; Aronsson A; Marions L; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2007 Oct; 22(10):2647-52. PubMed ID: 17652452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal misoprostol before copper IUD insertion after previous insertion failure: a double-blind, placebo-controlled, parallel-group, randomised clinical trial.
    Rasheedy R; Tamara TF; Allam IS; Abbas AM; Essam El-Din Abd El Salam N; Ferhad Ahmed A
    Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):222-226. PubMed ID: 31112079
    [No Abstract]   [Full Text] [Related]  

  • 5. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial.
    Swenson C; Turok DK; Ward K; Jacobson JC; Dermish A
    Obstet Gynecol; 2012 Aug; 120(2 Pt 1):341-7. PubMed ID: 22825094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT.
    Dijkhuizen K; Dekkers OM; Holleboom CA; de Groot CJ; Hellebrekers BW; van Roosmalen GJ; Janssen CA; Helmerhorst FM
    Hum Reprod; 2011 Feb; 26(2):323-9. PubMed ID: 21159683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy of Vaginal Misoprostol vs Vaginal Dinoprostone Administered 3 Hours Prior to Copper T380A Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial.
    Ashour ASA; El Sharkawy M; Ali AS; Keshta NHA; Shatat HBAE; El Mahy M
    J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):559-565. PubMed ID: 32330638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of provider experience with misoprostol to facilitate intrauterine device insertion in nulliparous women.
    Ward K; Jacobson JC; Turok DK; Murphy PA
    Contraception; 2011 Dec; 84(6):594-9. PubMed ID: 22078188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study.
    Fouda UM; Salah Eldin NM; Elsetohy KA; Tolba HA; Shaban MM; Sobh SM
    Contraception; 2016 Jun; 93(6):513-8. PubMed ID: 26852833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT.
    Bahamondes MV; Espejo-Arce X; Bahamondes L
    Hum Reprod; 2015 Aug; 30(8):1861-6. PubMed ID: 26040478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial.
    Abbas AM; Abdellah MS; Khalaf M; Bahloul M; Abdellah NH; Ali MK; Abdelmagied AM
    Contraception; 2017 Mar; 95(3):251-256. PubMed ID: 27823944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women.
    Edelman AB; Schaefer E; Olson A; Van Houten L; Bednarek P; Leclair C; Jensen JT
    Contraception; 2011 Sep; 84(3):234-9. PubMed ID: 21843686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of vaginal misoprostol prior to IUD insertion in women with previous caesarean delivery: a randomised controlled trial.
    Maged AM; Youssef G; Eldaly A; Omran E; El Naggar M; Abdel Hak A; Kotb A; Ogila AI
    Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):32-37. PubMed ID: 29393690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial.
    Lathrop E; Haddad L; McWhorter CP; Goedken P
    Contraception; 2013 Dec; 88(6):725-9. PubMed ID: 24034580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol administration prior to intrauterine contraceptive device insertion: a systematic review and meta-analysis of randomised controlled trials.
    Tassi A; Parisi N; Londero AP
    Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):76-86. PubMed ID: 31914331
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic vaginal dinoprostone administration six hours prior to copper-T380A intrauterine device insertion in nulliparous women: A randomized controlled trial.
    Samy A; Kasem MFY; El Lithy A; Ibrahim AM; El Mahy M; Hussein AH; A-Wahab H; Hussien AH; Allah AAMA; El Din Wali AA; Soliman HH; Masoud AT; Abdou H; Hussein M; Abdella RM; Mostafa M; Zaki SS
    Contraception; 2020 Mar; 101(3):162-166. PubMed ID: 31811839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy?
    Elkhouly NI; Maher MA
    Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):222-226. PubMed ID: 28463028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery.
    Shady NW; Farouk HA; Sallam HF
    Contraception; 2023 Apr; 120():109788. PubMed ID: 35183498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for pain with intrauterine device insertion.
    Allen RH; Bartz D; Grimes DA; Hubacher D; O'Brien P
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007373. PubMed ID: 19588429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.